Dr Rittwika Bhattacharya

PhD (Senior Scientist)

Research Student: Mr Arijit Ghosh (registered to JU for Ph.D), Ms Minakshi Sen (supervising a part of her work

Old Ph.D awarded student: Dr Sourav Kumar Nandi

Research grant: As co-PI for the project “Alteration of BMI-1 and its associated oncogenic pathways as prognostic marker for of Gall bladder carcinoma: association with Salmonellosis and/or cholelithiasis “supported by Sri Sri Mohananda Cancer Fund, UK, from May 2024.

Publications:

1.     Nandi SK, Chatterjee N, Roychowdhury T, Pradhan A, Moiz S, Manna K, Sarkar DK, Dhar P, Dutta A, Mukhopadhyay S, Bhattacharya R*. Kaempferol with Verapamil impeded panoramic chemoevasion pathways in breast cancer through ROS overproduction and disruption of lysosomal biogenesis. Phytomedicine. 2023 May;113:154689. doi: 10.1016/j.phymed.2023.154689.

2.     Bhattacharya R*, Ghosh A, Mukhopadhyay S. High-grade serous ovarian carcinoma, the "Achiles' hill" for clinicians and molecular biologists: a molecular insight. Mol Biol Rep. 2023 Nov;50(11):9511-9519. doi: 10.1007/s11033-023-08760-3.

3.     Nandi SK, Roychowdhury T, Chattopadhyay S, Basu S, Chatterjee K, Choudhury P, Banerjee N, Saha P, Mukhopadhyay S*, Mukhopadhyay A, Bhattacharya R*. Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil. Toxicol Appl Pharmacol. 2022 Feb 15;437:115887. doi: 10.1016/j.taap.2022.115887.

4.     Nandi SK, Pradhan A, Das B, Das B, Basu S, Mallick B, Dutta A, Sarkar DK, Mukhopadhyay A, Mukhopadhyay S*, Bhattacharya R*. Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways. Pathol Res Pract. 2022; 237:154029. doi: 10.1016/j.prp.2022.154029.

5.     Nandi SK, Basu S, Bhattacharjya A, Dey Ghosh R, Bose CK, Mukhopadhyay S, Bhattacharya R*. Interplay of gut microbiome, fatty acids, and the endocannabinoid system in regulating development, progression, immunomodulation, and chemoresistance of cancer. Nutrition. 2022; 103-104:111787. doi: 10.1016/j.nut.2022.111787.

6.     Bhattacharya R*, Mukhopadhyay S, Ghosh D. A Holistic standpoint of Melatonin supplementation on cancer treatment outcome. J Clin Biomed Sci 2021; 11(1): 05-14.

7.     Ghosh A, Roychowdhury T, Nandi R, Maiti R, Ghosh NN, Molla SA, Mukhopadhyay S, Prodhan C, Chaudhury K, Das P, Sarkar NK, Chattopadhyay S, Bhattacharya R*, Bose CK*, Maiti DK*. Inhibitory role of a smart nano-trifattyglyceride of Moringa oleifera root in epithelial ovarian cancer, through attenuation of FSHR - c-Myc axis. J Tradit Complement Med. 2021 Apr 7;11(6):481-492. doi: 10.1016/j.jtcme.2021.03.005.

8.     Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, Roychowdhury T, Banerjee N, Chatterjee S, Bhattacharya R, Roy R, Mukhopadhyay A, Mogare D, Chattopadhyay S.SMAR1 favorsimmunosurveillance of cancer cells by modulating calnexin and MHC I expression.Neoplasia. 2019 Aug 15;21(10):945-962. doi: 10.1016/j.neo.2019.07.002.

10.   Bhattacharya R, Panda CK, Nandi S, Mukhopadhyay A. An insight into metastasis: Random or evolving paradigms? Pathol Res Pract. 2018; 214(8):1064-1073. doi: 10.1016/j.prp.2018.06.017.

11.   K Banerjee, R Bhattacharya, A Mukhopadhyay. Molecular Signatures of Colorectal Cancer: A Prospective Study for Improvisation of Treatment Strategies. Adv. Biores. 2017;  8(5): 01‐11. DOI: 10.15515/abr.0976‐4585.8.5.111.